These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 37039609)

  • 1. Mitophagy in metabolic syndrome.
    Miao MQ; Han YB; Liu L
    J Clin Hypertens (Greenwich); 2023 May; 25(5):397-403. PubMed ID: 37039609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitophagy: A potential therapeutic target for insulin resistance.
    Ning P; Jiang X; Yang J; Zhang J; Yang F; Cao H
    Front Physiol; 2022; 13():957968. PubMed ID: 36082218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns.
    Su Z; Nie Y; Huang X; Zhu Y; Feng B; Tang L; Zheng G
    Front Pharmacol; 2019; 10():1193. PubMed ID: 31649547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitophagy and mitochondrial dynamics in type 2 diabetes mellitus treatment.
    Shan Z; Fa WH; Tian CR; Yuan CS; Jie N
    Aging (Albany NY); 2022 Mar; 14(6):2902-2919. PubMed ID: 35332108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of mitophagy receptor FUNDC1 impairs mitochondrial quality and aggravates dietary-induced obesity and metabolic syndrome.
    Wu H; Wang Y; Li W; Chen H; Du L; Liu D; Wang X; Xu T; Liu L; Chen Q
    Autophagy; 2019 Nov; 15(11):1882-1898. PubMed ID: 30898010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance.
    He F; Huang Y; Song Z; Zhou HJ; Zhang H; Perry RJ; Shulman GI; Min W
    J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33315085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders.
    Su Z; Guo Y; Huang X; Feng B; Tang L; Zheng G; Zhu Y
    Front Cell Dev Biol; 2021; 9():686820. PubMed ID: 34414181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mitophagy in the regulation of mitochondrial energetic status in neurons.
    Han S; Zhang M; Jeong YY; Margolis DJ; Cai Q
    Autophagy; 2021 Dec; 17(12):4182-4201. PubMed ID: 33757395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of peroxisome proliferator-activated receptors γ (PPARγ) in obesity and insulin resistance].
    Chmielewska-Kassassir M; Woźniak LA; Ogrodniczek P; Wójcik M
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1283-99. PubMed ID: 24379269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of mitophagy that regulate mitochondrial quality control play crucial role in diverse pathophysiology.
    De R; Mazumder S; Bandyopadhyay U
    Cell Biol Toxicol; 2021 Jun; 37(3):333-366. PubMed ID: 33067701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
    Lau CH; Muniandy S
    Cardiovasc Diabetol; 2011 Jan; 10():8. PubMed ID: 21251282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Oxidative Stress in Metabolic Syndrome.
    Masenga SK; Kabwe LS; Chakulya M; Kirabo A
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction in metabolic syndrome.
    Prasun P
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165838. PubMed ID: 32428560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of mitoquinone against impaired mitochondrial homeostasis in metabolic syndrome.
    Yang J; Suo H; Song J
    Crit Rev Food Sci Nutr; 2021; 61(22):3857-3875. PubMed ID: 32815398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of irs-1 polymorphism with various components of the metabolic syndrome in hypertensive patients.
    Kochuieva M; Psarova V; Ruban L; Kyrychenko N; Alypova O; Matlai O; Shalimova A
    Wiad Lek; 2019 Aug; 72(8):1484-1498. PubMed ID: 32003208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1.
    Seillier M; Pouyet L; N'Guessan P; Nollet M; Capo F; Guillaumond F; Peyta L; Dumas JF; Varrault A; Bertrand G; Bonnafous S; Tran A; Meur G; Marchetti P; Ravier MA; Dalle S; Gual P; Muller D; Rutter GA; Servais S; Iovanna JL; Carrier A
    EMBO Mol Med; 2015 Jun; 7(6):802-18. PubMed ID: 25828351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glitazones and the metabolic syndrome: mechanism of action, pathophysiology and therapeutic indications].
    Gomes MB
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):271-80. PubMed ID: 16767293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Insights Into the Anti-aging Role of Mitophagy.
    Markaki M; Palikaras K; Tavernarakis N
    Int Rev Cell Mol Biol; 2018; 340():169-208. PubMed ID: 30072091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.